<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04257409</url>
  </required_header>
  <id_info>
    <org_study_id>546417</org_study_id>
    <nct_id>NCT04257409</nct_id>
  </id_info>
  <brief_title>Musculoskeletal Changes After Physiotherapeutic Intervention in Podiatric Subjects</brief_title>
  <acronym>BIONEDIAN</acronym>
  <official_title>Musculoskeletal Changes Induced by Physiotherapeutic Intervention, and Their Impact on the Induction of Diabetic Foot Syndrome and Psychosocial Status in Type 2 Diabetes Mellitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mgr. Eliška Vrátná</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Vladimíra Fejfarová, MD, PhD</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>prof. Ing. Václav Bunc, CSc</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Charles University, Czech Republic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The recurrence of diabetic foot ulcers (DFU) is a key problem in podiatric care. It is very
      often given by biomechanical abnormalities frequently present in those patients. The aim of
      our randomized controlled study is to find possible changes as of plantar pressures as of
      biomechanics of the ankle and small joints in patients with type 2 diabetes mellitus with
      different degrees of neuropathy. During this project, investigators will examine the possible
      impact of 12-week lasting intervention program on the distribution of plantar pressures,
      joint mobility and muscle strength of lower limbs. The incidence of ulcerations /
      reulcerations and changes of psychosocial characteristics will be evaluated during the study
      period.

      Approximately 60 patients with Type 2 diabetes mellitus will be included into the study.
      These patients will be randomized into 3 study groups - patients with type 2 DM with mild
      form of peripheral sensory neuropathy (20 subjects), patient with severe peripheral
      neuropathy (20 subjects) and those with diabetic foot syndrome, without active lesion (20
      subjects). All patients will undergo 12 week lasting active intervention program consisting
      of recommendations by a physiotherapist focusing on the improvement of physical fitness,
      muscle strength and foot joint improvement. Control group will be consisted of 20 patients
      with healed diabetic foot.

      The outcomes of this project will try to objectively verify in the randomized controlled
      trial the impact of exercise on lower limb biomechanics, mobility, self-sufficiency, quality
      of life in patients with type 2 diabetes mellitus at risk or already developed diabetic foot
      syndrome.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Anticipated">January 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>60 patients with Type 2 diabetes mellitus. These patients will be randomized into 3 study groups - patients with type 2 DM with mild form of peripheral sensory neuropathy (20 subjects), patient with severe peripheral neuropathy (20 subjects) and those with diabetic foot syndrome, without active lesion (20 subjects). All patients will undergo 12 week lasting active intervention program consisting of recommendations by a physiotherapist focusing on the improvement of physical fitness, muscle strength and foot joint improvement. Control group will be consisted of 20 patients with healed diabetic foot.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>randomization of diabetic patients with healed diabetic foot according the randomization scheme</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Biomechanics- plantar pressures</measure>
    <time_frame>changes after 12 weeks, 24 weeks</time_frame>
    <description>plantar pressures will be evaluated by pedobarograph (in Newtons)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Biomechanics- biomechanics of the ankle</measure>
    <time_frame>changes after 12 weeks, 24 weeks</time_frame>
    <description>biomechanics of the ankle will be assessed by goniometry in angles</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Biomechanics- changes of foot joint angles</measure>
    <time_frame>changes after 12 weeks, 24 weeks</time_frame>
    <description>changes of foot joint agles will be evaluated by measurement of X-Rays bones angles - calcaneal pitch, talar-1st metatarsal angle and lateral Talocalcaneal angle</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fitness - physical activity</measure>
    <time_frame>changes after 12 weeks, 24 weeks</time_frame>
    <description>The amount of physical activity will be assessed by IPAQ questioners</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fitness - muscle strength</measure>
    <time_frame>changes after 12 weeks, 24 weeks</time_frame>
    <description>Muscle strength will be measured by dynamometry in Newtons</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fitness - senior fitness</measure>
    <time_frame>changes after 12 weeks, 24 weeks</time_frame>
    <description>fitness will be assessed by seniorfittest containing 2 minutes step test (steps/2 min) and test of sitting (sits/30 seconds)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ulceration/reulceration</measure>
    <time_frame>changes after 12 weeks, 24 weeks</time_frame>
    <description>detection of the incidence of ulceration/reulceration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychosocial changes - quality of life</measure>
    <time_frame>changes after 12 weeks, 24 weeks</time_frame>
    <description>Quality of life will be evaluated by WHO-QoL Bref test (4 domains - high values mean bettr findings</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychosocial changes - depression</measure>
    <time_frame>changes after 12 weeks, 24 weeks</time_frame>
    <description>Depression status will be asessed by Geriatric Depression Scale (GDS) scale - minimum 0, maximum 30 points (higher then 9 points- mild form of depression, higher then 20 - severe depression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychosocial changes - stress readaptation</measure>
    <time_frame>changes after 12 weeks, 24 weeks</time_frame>
    <description>Adaptation to stress will be detected by Stress Readaption Scale (0-400 points) - points higher then 150 - higher risk of worse stress readaptation and therefore higher risk of somatisation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolism - glucose control</measure>
    <time_frame>changes after 12 weeks, 24 weeks</time_frame>
    <description>Investigators will be loked for metabolic changes in diabetes control (HbA1c in mmol/mol, glycemia in mmol/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolism - lipid profile</measure>
    <time_frame>changes after 12 weeks, 24 weeks</time_frame>
    <description>The authors will control lipid profiles (Total-, HDL-, LDL-cholesterol in umol/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolism - myokines</measure>
    <time_frame>changes after 12 weeks, 24 weeks</time_frame>
    <description>Patients will be checked for changes in selected cytokines nad myokines (IL-4,6,7,8,15 in pg/ml, myostatin in pg/ml, irisin in ng/ml, FGF-21 in pg/ml)</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Prevention of Diabetic Foot</condition>
  <arm_group>
    <arm_group_label>DF patient active</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with Type 2 diabetes mellitus and diabetic foot, whose have healed diabetic foot ulcers</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DF patient control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with Type 2 diabetes mellitus and diabetic foot, whose have healed diabetic foot ulcers</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diabetic patient with mild neuropathy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with Type 2 diabetes mellitus with mild form of peripheral sensory neuropathy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diabetic patient with severe neuropathy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with Type 2 diabetes mellitus with severe form of peripheral sensory neuropathy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Physical intervention by exercise</intervention_name>
    <description>12 week lasting exercise intervention</description>
    <arm_group_label>DF patient active</arm_group_label>
    <arm_group_label>DF patient control</arm_group_label>
    <arm_group_label>Diabetic patient with mild neuropathy</arm_group_label>
    <arm_group_label>Diabetic patient with severe neuropathy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 diabetes mellitus

          -  sensoric neuropathy (mild - based on VPV 15-30 V or EMG results, severe - based on VPT
             above 50 V or EMG results)

          -  diabetic foot with healed diabetic foot ulcers, inactive Charcot foot

        Exclusion Criteria:

          -  impossibility to exercise

          -  amaurosis

          -  non-compliance

          -  critical limb ischemia

          -  active ulcer, surgical wound

          -  active Charcot foot

          -  active carcinoma

          -  recent stroke (last 8 weeks)

          -  recent myocardial infarction (last 8 weeks)

          -  recent PTA, PCI, bypass (last 8 weeks)

          -  myopathy

          -  rheumatoid arthritis

          -  cox-, gonartrosis of 3rd -4th grade.
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>30-75 years</gender_description>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Eliška Vrátná, Mgr.</last_name>
    <phone>+420774549214</phone>
    <email>vratnae@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vladimíra Fejfarová, MD, PhD</last_name>
    <phone>+420603877381</phone>
    <email>vlfe@medicon.cz</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institute for Clinical and Experimental Medicine</name>
      <address>
        <city>Prague</city>
        <zip>14200</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eliška Vrátná, Mgr.</last_name>
      <phone>+420774549214</phone>
      <email>vratnae@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Vladimíra Fejfarová, MD, PhD</last_name>
      <phone>+420603877381</phone>
      <email>vlfe@medicon.cz</email>
    </contact_backup>
    <investigator>
      <last_name>Jitka Hazdrová, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>December 15, 2019</study_first_submitted>
  <study_first_submitted_qc>February 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 6, 2020</study_first_posted>
  <last_update_submitted>February 3, 2020</last_update_submitted>
  <last_update_submitted_qc>February 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Charles University, Czech Republic</investigator_affiliation>
    <investigator_full_name>Mgr. Eliška Vrátná</investigator_full_name>
    <investigator_title>Faculty of Physical Education and Sport</investigator_title>
  </responsible_party>
  <keyword>diabetic foot</keyword>
  <keyword>biomechanics</keyword>
  <keyword>quality of life</keyword>
  <keyword>prevention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetic Foot</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Possible to look at the data in documentation site</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

